Sumatriptan Nasal Spray for Acute Migraine

Open Access

|Dec 1997

Ryan R Elkind A Baker CC Mullican W DeBussey S Asgharnejad M Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies Neurology 1997 Nov 49 5 1225 1230 10.1212/WNL.49.5.1225 9371898
Open DOI Search in Google Scholar Back to article
Rapoport AM Ramadan NM Adelman JU Mathew NT Elkind AH Kudrow DB Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group Neurology 1997 Nov 49 5 1210 1218 10.1212/WNL.49.5.1210 9371896
Open DOI Search in Google Scholar Back to article
Solomon GD Cady RK Klapper JA Earl NL Saper JR Ramadan NM Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group Neurology 1997 Nov 49 5 1219 1225 10.1212/WNL.49.5.1219 9371897
Open DOI Search in Google Scholar Back to article
Gardner K Barmada MM Ptacek LJ Hoffman EP A new locus for hemiplegic migraine maps to chromosome 1q31 Neurology 1997 Nov 49 5 1231 1238 10.1212/WNL.49.5.1231 9371899
Open DOI Search in Google Scholar Back to article

Language: English

Page range: 95 - 95

Published on: Dec 1, 1997

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.